Subjective Tinnitus Clinical Trial
Official title:
Collaborative Tinnitus Research at Washington University
The goal of this trial to see if repetitive transcranial magnetic stimulation (rTMS) to the
hearing area of the brain can lessen the perception of tinnitus. rTMS uses a strong magnet
and when placed against the scalp generates a small electrical field within the brain.
Depending on the frequency of the stimulation, this electrical field can either decrease or
increase the electrical excitability of the brain. In this study, low-frequency stimulation
will be used, which is thought to decrease nerve activity. It is this electrical excitability
of the brain that is thought to be responsible for tinnitus.
The hypothesis of this study is that rTMS can decrease the perception of tinnitus.
This will be a cross-over randomized trial. The order of the treatments received will be
randomly selected and the participant will not be told which treatment they are receiving.
Subjects will fall into one of the four treatment groups described below:
1. 2 weeks of active rTMS treatment followed by washout and then by 2 weeks sham
2. 2 weeks of sham followed by washout and then 2 weeks of active rTMS treatment
3. 4 weeks of active rTMS treatment followed by washout and then 4 weeks of sham
4. 4 weeks of sham followed by washout and then 4 weeks of active rTMS treatment
For the washout period between the two interventions, we will plan a minimum of 2 weeks to
avoid the problem of carryover effects. Prior to starting the next intervention after the
washout period, we will re-assess subject's tinnitus severity. To ensure no carryover effect,
the washout period will be extended for those subjects whose tinnitus severity, as defined by
the THI, is more than 20 points different than their baseline THI score.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00955799 -
Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
|
Phase 3 | |
Completed |
NCT00739635 -
Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
|
Phase 3 | |
Completed |
NCT03550430 -
Neurofeedback for Tinnitus - Does Frequency Specificity Matter?
|
N/A | |
Completed |
NCT00772980 -
Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
|
Phase 3 | |
Completed |
NCT04829214 -
OTO-313 in Subjects With Unilateral Subjective Tinnitus
|
Phase 2 | |
Completed |
NCT01268449 -
Evaluation of Low Dose Laser in Treatment of Tinnitus
|
Phase 2 | |
Completed |
NCT01177137 -
Tinnitus Retraining Therapy Trial
|
Phase 3 | |
Terminated |
NCT00827008 -
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
|
Phase 3 | |
Unknown status |
NCT00555776 -
Effect of Gabapentin on Idiopathic Subjective Tinnitus
|
Phase 2 | |
Completed |
NCT05265949 -
The Effects of Weight Loss on Tinnitus Symptoms
|
N/A | |
Completed |
NCT04696588 -
Neck Kinesiotherapy and Massage in Tinnitus Treatment
|
N/A |